Effect of the peroxisome proliferator ciprofibrate on lipid peroxidation and 8-hydroxydeoxyguanosine formation in transgenic mice with elevated hepatic catalase activity

Free Radical Biology and Medicine

Volumn 24, Issue 9, 1998, Pages 1430-1436

  Nilakantan, Vani ^a   Spear, Brett T ^a   Glauert, Howard P ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

8 Hydroxydeoxyguanosine; Catalase; Ciprofibrate; Conjugated dienes; Free radical; Malondialdehyde; Peroxisome

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CATALASE; CIPROFIBRATE;

ANIMAL EXPERIMENT; ARTICLE; CANCER RISK; CHEMICAL CARCINOGENESIS; DRUG EFFECT; LIPID PEROXIDATION; LIVER CARCINOMA; LIVER METABOLISM; MOUSE; NONHUMAN; PEROXISOME; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ADMINISTRATION, ORAL; ANIMALS; CATALASE; CLOFIBRIC ACID; DEOXYGUANOSINE; ENZYME ACTIVATION; FEMALE; LIPID PEROXIDATION; LIVER; MICE; MICE, TRANSGENIC; MICROSOMES, LIVER; PEROXISOME PROLIFERATORS;

ANIMALIA; MUS MUSCULUS;

EID: 0031864194     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(98)00007-0     Document Type: Article

References (51)

1. Reddy J. K., Lalwani N. D. Carcinogenesis by hepatic peroxisome proliferators evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans . CRC Crit. Rev. Toxicol. 12:1983;1-58.
2. Reddy J. K., Azarnoff D. L., Hignite C. E. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature. 283:1980;397-398.
3. 32P-Postlabeling analysis of peroxisome proliferator-DNA adduct formation in rat liver in vivo and hepatocytes in vitro. Carcinogenesis. 6:1985;933-936.
4. 2. Biochim. Biophys. Acta. 272:1972;539-548.
5. Tomaszewski K. E., Agarwal D. K., Melnick R. L. In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators. Carcinogenesis. 7:1986;1871-1876.
6. Elliott B. M., Dodd N. J. F., Elcombe C. R. Increased hydroxyl radical production in liver peroxisomal fractions from rats treated with peroxisome proliferators. Carcinogenesis. 7:1986;795-799.
7. Srinivasan S., Glauert H. P. Formation of 5-hydroxymethyl-2′-deoxyuridine in hepatic DNA of rats treated with gamma-irradiation, diethylnitrosamine, 2-acetylaminofluorene or the peroxisome proliferator ciprofibrate. Carcinogenesis. 11:1990;2021-2024.
8. Huang C. Y., Wilson M. W., Lay L. T., Chow C. K., Robertson L. W., Glauert H. P. Increased 8-hydroxydeoxyguanosine in hepatic DNA of rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid. Cancer Lett. 87:1994;223-228.
9. Kasai H., Okada Y., Nishimura S., Rao M. S., Reddy J. K. Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res. 49:1989;2603-2605.
10. Takagi A., Sai K., Umemura T., Hasegawa R., Kurokawa Y. Significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats following short-term exposure to the peroxisome proliferators di(2-ethylhexyl)phthalate and di(2-ethylhexyl)adipate. Jpn. J. Cancer Res. 81:1990;213-215.
11. Takagi A., Sai K., Umemura T., Hasegawa R., Kurokawa Y. Relationship between hepatic peroxisome proliferation and 8-hydroxydeoxyguanosine formation in liver DNA of rats following long-term exposure to three peroxisome proliferators; di(2-ethylhexyl)phthalate, aluminium clofibrate and simfibrate. Cancer Lett. 53:1990;33-38.
12. Takagi A., Sai K., Umemura T., Hasegawa R., Kurokawa Y. Short-term exposure to the peroxisome proliferators, perfluorooctanoic acid and perfluorodecanoic acid, causes significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats. Cancer Lett. 57:1991;55-60.
13. Cattley R. C., Grover S. E. Elevated 8-hydroxyguanosine levels in hepatic DNA of rats following exposure to peroxisome proliferators relationship to carcinogenesis and nuclear localization . Carcinogenesis. 14:1993;2495-2499.
14. Sausen P. J., Lee D. C., Rose M. L., Cattley R. C. Elevated 8-hydroxydeoxyguanosine levels in hepatic DNA of rats following exposure to peroxisome proliferators relationship to mitochondrial alterations . Carcinogenesis. 16:1995;1795-1801.
15. Hegi M. E., Ulrich D., Sagelsdorff P., Richter C., Lutz W. K. No measurable increase in thymidine glycol or 8-hydroxydeoxyguanosine in liver DNA of rats treated with nafenopin or choline-devoid low-methionine diet. Mutat. Res. 238:1990;325-329.
16. Marsman D. S., Goldsworthy T. L., Popp J. A. Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid. Carcinogenesis. 13:1992;1011-1017.
17. Price S. C., Hinton R. H., Mitchell F. E., Hall D. E., Grasso P., Blane G. F., Bridges J. W. Time and dose study on the response of rats to the hypolipidaemic drug fenofibrate. Toxicology. 41:1986;169-191.
18. Goel S. K., Lalwani N. D., Reddy J. K. Peroxisome proliferation and lipid peroxidation in rat liver. Cancer Res. 46:1986;1324-1330.
19. Lake B. G., Kozlen S. L., Evans J. G., Gray T. J. B., Young P. J., Gangolli S. D. Effect of prolonged administration of clofibric acid and di-(2-ethylhexyl)phthalate on hepatic enzyme activities and lipid peroxidation in the rat. Toxicology. 44:1987;213-228.
20. Conway J. G., Tomaszewski K. E., Olson M. J., Cattley R. C., Marsman D. S., Popp J. A. Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643. Carcinogenesis. 10:1989;513-519.
21. Glauert H. P., Srinivasan S., Tatum V. L., Chen L. C., Saxon D. M., Lay L. T., Borges T., Baker M., Chen L. H., Robertson L. W., Chow C. K. Effects of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cellular antioxidants and lipid peroxidation in rats. Biochem. Pharmacol. 43:1992;1353-1359.
22. Elliott B. M., Elcombe C. R. Lack of DNA damage or lipid peroxidation measured in vivo in the rat liver following treatment with peroxisomal proliferators. Carcinogenesis. 8:1987;1213-1218.
23. Nakagawa M., Ishihara N., Shimokawa T., Kojima S. Effect of clofibrate on lipid peroxidation in rats treated with aspirin and 4-pentenoic acid. J. Biochem. 101:1987;81-88.
24. Huber W., Kraupp-Grasl B., Esterbauer H., Schulte-Hermann R. Role of oxidative stress in age dependent hepatocarcinogenesis by the peroxisome proliferator nafenopin in the rat. Cancer Res. 51:1991;1789-1792.
25. Hayashi F., Tamura H., Yamada J., Kasai H., Suga T. Characteristics of the hepatocarcinogenesis caused by DEHA, a peroxisome proliferator, in male F-344 rats. Carcinogenesis. 15:1994;2215-2219.
26. Cai Y. N., Appelkvist E. L., Depierre J. W. Hepatic oxidative stress and related defenses during treatment of mice with acetylsalicylic acid and other peroxisome proliferators. J. Biochem. Toxicol. 10:1995;87-94.
27. Nilakantan V., Li Y., Glauert H. P., Spear B. T. Increased liver-specific catalase activity in transgenic mice. DNA Cell Biol. 15:1996;625-630.
28. Poosch M. S., Yamazaki R. K. Determination of peroxisomal fatty acyl-CoA oxidase activity using a lauroyl-CoA-based fluorometric assay. Biochim. Biophys. Acta. 884:1986;585-593.
29. Giera D. D., van Lier R. B. L. A convenient method for the determination of hepatic lauric acid omega-oxidation based on solvent partition. Fund. Appl. Toxicol. 16:1991;348-355.
30. Beers R. F., Sizer J. W. A spectrophotometric method of measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem. 195:1952;133-140.
31. Lawrence R. A., Burk R. F. Glutathione peroxidase activity in selenium-deficient rat liver. Biochem. Biophys. Res. Commun. 71:1976;952-958.
32. Li X. Y., Chow C. K. An improved method for the measurement of malondialdehyde in biological samples. Lipids. 29:1994;73-75.
33. Recknagel R. O., Glende E. A. Spectrophotometric detection of lipid conjugated dienes. Meth. Enzymol. 105:1984;331-337.
34. Spelsberg T. C., Knowler J. T., Moses H. L. Specific methods for the isolation of nuclei from chick oviduct. Meth. Enzymol. 31:1974;263-279.
35. Adachi S., Zeisig M., Möller L. Improvements in the analytical method for 8-hydroxydeoxyguanosine in nuclear DNA. Carcinogenesis. 16:1995;253-258.
36. Gupta R. C. Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc. Natl. Acad. Sci. 81:1984;6943-6947.
37. Wei H., Frenkel K. In vivo formation of oxidized DNA bases in tumor promoter-treated mouse skin. Cancer Res. 51:1991;4443-4449.
38. Hayashi F., Tamura H., Yamada J., Kasai H., Suga T. Characteristics of the hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome proliferator, in male F-344 rats. Carcinogenesis. 15:1994;2215-2219.
39. Kasai H., Crain P. F., Kuchino Y., Nishimura S., Ootsuyama A., Tanooka H. Formation of 8-hydroxyguanine moeity in cellular DNA by agents producing oxygen radicals and evidence for its repair. Carcinogenesis. 7:1986;1849-1851.
40. Rao M. S., Reddy J. K. Peroxisome proliferation and hepatocarcinogenesis. Carcinogenesis. 8:1987;631-636.
41. Hawkins J. M., Jones W. E., Bonner F. W., Gibson G. G. The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney. Drug Metab. Rev. 18:1987;441-515.
42. Bondy S. C., Naderi S. Contribution of hepatic cytochrome P450 systems to the generation of reactive oxygen species. Biochem. Pharmacol. 48:1994;155-159.
43. Boveris A., Oshino N., Chance B. The cellular production of hydrogen peroxide. Biochem. J. 128:1972;3930-3933.
44. 2-generating peroxisomal fatty acyl-CoA oxidase. Proc. Natl. Acad. Sci. 92:1995;7080-7084.
45. 2-generating peroxisomal urate oxidase. Cancer Res. 56:1996;4846-4852.
46. Halliwell B., Gutteridge J. M. C. Role of free radicals and catalytic metal ions in human disease an overview . Meth. Enzymol. 186:1990;1-85.
47. Reddy J. K., Lalwani N. D., Reddy M. K., Qureshi S. A. Excessive accumulation of autofluorescent lipofuscin in the liver during hepatocarcinogenesis by methyl clofenapate and other hypolipidemic peroxisome proliferators. Cancer Res. 42:1982;259-266.
48. Kang Y. J., Chen Y., Epstein P. N. Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice. J. Biol. Chem. 271:1996;12610-12616.
49. Shibutani S., Takeshita M., Grollman A. P. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature. 349:1991;431-434.
50. Kuchino Y., Mori F., Kasai H., Inoue H., Iwai S., Miura K., Ohtsuka E., Nishimura S. DNA templates containing 8-OHdG are misread both at the modified base and at adjacent residues. Nature. 327:1987;77-79.
51. Wood M. L., Esteve A., Morningstar M. L., Kuziemko G. M., Essigmann J. M. Genetic effects of oxidative DNA damage - comparative mutagenesis of 7,8-dihydro-8-oxoguanine and 7,8-dihydro-8-oxoadenine in Escherichia coli. Nucleic Acids Res. 20:1992;6023-6032.